Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence Density of Invasive Fungal Infections during Primary Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Patients in a Tertiary Cancer Center, 2009 to 2011
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 2, Pages 865-873
Publisher
American Society for Microbiology
Online
2013-11-26
DOI
10.1128/aac.01525-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies
- (2013) Thomas R. Rogers et al. BRITISH JOURNAL OF HAEMATOLOGY
- Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
- (2013) C Orla Morrissey et al. LANCET INFECTIOUS DISEASES
- Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study
- (2012) J. Auberger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance to echinocandins comes at a cost
- (2012) Ronen Ben-Ami et al. Virulence
- Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
- (2011) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Invasive Mycoses: Strategies for Effective Management
- (2011) Dimitrios P. Kontoyiannis AMERICAN JOURNAL OF MEDICINE
- Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections
- (2011) Russell E Lewis AMERICAN JOURNAL OF THERAPEUTICS
- Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France
- (2011) Elodie Blanchard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?
- (2011) Thomas R. Rogers et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
- (2011) M. Z. R. Gomes et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience
- (2011) C. Girmenia et al. HAEMATOLOGICA
- Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
- (2011) M. R. Ananda-Rajah et al. HAEMATOLOGICA
- Empirical versus pre-emptive antifungal therapy for persistent febrile neutropenia
- (2011) E. Castagnola et al. HAEMATOLOGICA
- Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review
- (2011) Mahipal Sinnollareddy et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay
- (2011) A. M. Tortorano et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Current Concepts in Antifungal Pharmacology
- (2011) Russell E. Lewis MAYO CLINIC PROCEEDINGS
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success
- (2010) D P Kontoyiannis BONE MARROW TRANSPLANTATION
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?
- (2010) Konstantinos Leventakos et al. CLINICAL INFECTIOUS DISEASES
- Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
- (2010) J. J. Vehreschild et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends
- (2010) Morena Caira et al. MEDICAL MYCOLOGY
- Clinical experience with posaconazole prophylaxis - a retrospective analysis in a haematological unit
- (2010) J. Hahn et al. MYCOSES
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)
- (2009) Nikolaos V. Sipsas et al. CANCER
- Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients
- (2009) Maria J. G. T. Rüping et al. MYCOSES
- Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
- (2009) Gloria N. Mattiuzzi et al. SUPPORTIVE CARE IN CANCER
- Changes in causes of death over time after treatment for invasive aspergillosis
- (2008) John R. Wingard et al. CANCER
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
- (2008) Morena Caira et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2008) O. A. Cornely et al. HAEMATOLOGICA
- Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy
- (2008) M. A. Slavin et al. INTERNAL MEDICINE JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started